- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 39/02 - Antidotes
Patent holdings for IPC class A61P 39/02
Total number of patents in this class: 456
10-year publication summary
|
20
|
14
|
17
|
31
|
28
|
40
|
34
|
44
|
35
|
27
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20153 |
11 |
| Kureha Corporation | 1040 |
7 |
| Centre National de La Recherche Scientifique | 10595 |
6 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2193 |
6 |
| Jiangnan University | 1543 |
6 |
| Ophirex, Inc. | 20 |
6 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10959 |
5 |
| Universite de Strasbourg | 688 |
5 |
| Murata Manufacturing Co., Ltd. | 24843 |
4 |
| Daiichi Sankyo Company, Limited | 1875 |
4 |
| Danmarks Tekniske Universitet | 983 |
4 |
| The Doshisha | 226 |
4 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 374 |
4 |
| Her Majesty the Queen in Right of Canada, as represented by the Minister of National Defence | 202 |
4 |
| Kyowa Hakko Bio Co., Ltd. | 293 |
4 |
| Shionogi & Co., Ltd. | 844 |
4 |
| ZBiotics Company | 21 |
4 |
| Naval Medical University | 4 |
4 |
| Takeda Pharmaceutical Company Limited | 2704 |
3 |
| Asahi Group Holdings, Ltd. | 442 |
3 |
| Other owners | 358 |